The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer

被引:0
|
作者
Xiaofeng Gong
Danyu Du
Yanran Deng
Yuqi Zhou
Li Sun
Shengtao Yuan
机构
[1] China Pharmaceutical University,Jiangsu Key Laboratory of Drug Screening
[2] China Pharmaceutical University,Jiangsu Center for Pharmacodynamics Research and Evaluation
来源
Investigational New Drugs | 2020年 / 38卷
关键词
Ubiquitination; HUWE1; Cancer therapeutics; Drug discovery;
D O I
暂无
中图分类号
学科分类号
摘要
E3 ligases are a class of critical enzymes that can catalyse the transfer of ubiquitin (Ub) from an E2 enzyme to the substrate and are essential to cellular processes. The E3 ligase HUWE1 (also known as ARF-BP1, HECTH9, HSPC272, Ib772, LASU1, MULE, URE-B1, UREB1, and HECT, UBA and WWE domain-containing E3 ubiquitin protein ligase 1) is encoded by the huwe1 gene. HUWE1 is a key regulator of the DNA damage response, transcription, autophagy, apoptosis and metabolism in a variety of cancers. Due to its pivotal role in conferring substrate specificity, HUWE1 has attracted enormous attention as a promising anticancer drug target. In this review, we indicate the specific molecular structure of HUWE1 and its role in various cellular signalling pathways and highlight new insights into HUWE1 in cancer. Finally, we discuss outstanding questions regarding HUWE1 in oncology and highlight its limitations in drug development and clinical guidance to better define the role of HUWE1 in multiple cancers.
引用
收藏
页码:515 / 524
页数:9
相关论文
共 50 条
  • [31] Novel insights into the SPOP E3 ubiquitin ligase: From the regulation of molecular mechanisms to tumorigenesis
    Li, Xian-Miao
    Wu, Huan-Lei
    Xia, Qi-Dong
    Zhou, Peng
    Wang, Shao-Gang
    Yu, Xiao
    Hu, Jia
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [32] Mkrn3 functions as a novel ubiquitin E3 ligase to inhibit Nptx1 during puberty initiation
    Liu, Huifang
    Kong, Xiangxin
    Chen, Fengling
    ONCOTARGET, 2017, 8 (49) : 85102 - 85109
  • [33] Ubiquitin chain specificities of E6AP E3 ligase and its HECT domain
    Kobayashi, Fuminori
    Nishiuchi, Takumi
    Takaki, Kento
    Konno, Hiroki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 496 (02) : 686 - 692
  • [34] E3 ubiquitin ligase HRD1 modulates the circadian clock through regulation of BMAL1 stability
    Guo, Dongkai
    Zhu, Yao
    Wang, Hongfeng
    Wang, Guanghui
    Wang, Cheng
    Ren, Haigang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (03) : 2639 - 2648
  • [35] The E3 Ubiquitin Ligase MID1 Catalyzes Ubiquitination and Cleavage of Fu
    Schweiger, Susann
    Dorn, Stephanie
    Fuchs, Melanie
    Koehler, Andrea
    Matthes, Frank
    Mueller, Eva-Christina
    Wanker, Erich
    Schneider, Rainer
    Krauss, Sybille
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (46) : 31805 - 31817
  • [36] Research Progress of E3 Ubiquitin Ligase Adaptor Protein Keap1
    Ni Xiao-Qi
    Chen Xi-Wei
    Jin Xiao-Feng
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2022, 49 (02) : 328 - 348
  • [37] H Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase
    Peter, Stefanie
    Bultinck, Jennyfer
    Myant, Kevin
    Jaenicke, Laura A.
    Walz, Susanne
    Muller, Judith
    Gmachl, Michael
    Treu, Matthias
    Boehmelt, Guido
    Ade, Carsten P.
    Schmitz, Werner
    Wiegering, Armin
    Otto, Christoph
    Popov, Nikita
    Sansom, Owen
    Kraut, Norbert
    Eilers, Martin
    EMBO MOLECULAR MEDICINE, 2014, 6 (12) : 1525 - 1541
  • [38] Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression
    David, Diana
    Surendran, Arun
    Thulaseedharan, Jissa V.
    Nair, Asha S.
    BMC CANCER, 2018, 18
  • [39] Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression
    Diana David
    Arun Surendran
    Jissa V. Thulaseedharan
    Asha S. Nair
    BMC Cancer, 18
  • [40] Insights Into the Biological Role of NEDD4L E3 Ubiquitin Ligase in Human Cancers
    Xie, Shangdan
    Xia, Lu
    Song, Yizuo
    Liu, Hejing
    Wang, Zhi-wei
    Zhu, Xueqiong
    FRONTIERS IN ONCOLOGY, 2021, 11